Breast Lesion Localization Market expected to generate $546.74 Million, CAGR: 5.70% CAGR by 2032

Breast Lesion Localization Market Size Worth $546.74 Million By 2032 | CAGR: 5.70%

The global breast lesion localization market size is expected to reach USD 546.74 million by 2032, according to a new study by Polaris Market Research. The report “Breast Lesion Localization Market Share, Size, Trends, Industry Analysis Report, By Type (Wire, Radioisotope, Magnetic, Electromagnetic Localization); By Usage; By End User; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The ongoing research activities on breast lesion localization are creating awareness among surgeons about the latest technologies in the global market. A study published in Science Direct in 2022 focused on the analysis of pre-operative breast & axillary localizations. They prepared a questionnaire and circulated it to the Society of Breast Imaging Physicians. They witnessed a correlation between academics and the use of radioactive seeds. Wireless localization devices were more prevalent in practices, with a larger proportion of radiologists who read mammography.

The number of breast radiologists with fellowship training in a practice was significantly correlated positively with the methods used to localize breast lesions. This study reveals that different practice types use different localization techniques for breast and axillary lesions. They found that wireless localization devices are more likely to be used in academic settings, and integrating the use of modern localization techniques may provide challenges for smaller and less specialised practices. This facilitates further research activities on the applications of different technologies to various conditions, which may assist doctors in choosing effective tools for particular health conditions for their patients.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below:

A study published in 2023 in PubMed Central focused on a systematic review of the localization technologies used by surgeons in treating non-palpable breast lesions. The most popular method out of those that are available is wire-guided localization (WGL). In the past twenty years, other methods (radioactive, magnetic, radar- or radiofrequency-based, and intraoperative ultrasound) have been developed with the goal of enhancing results and logistics. The study concluded that wire-free localization is preferred by patients more often, according to smaller research, but little is known about how surgeons and radiologists feel about these methods, facilitating a scope for future research activities on surgeon preferences towards various localization technologies. The rising research activities will create growth potential for the breast lesion localization market in the coming years.

Breast Lesion Localization Market Report Highlights

  • Electromagnetic segment is anticipated to witness the highest growth in the coming years due to its higher effectiveness.
  • Breast Conservation segment accounted for the largest market share owing to rising concerns about breast appearance.
  • Ambulatory surgical center segment is projected to experience a larger revenue share due to its growing adoption.
  • North America is projected to register a largest growth rate in the study period owing to the growing government initiatives to eliminate breast cancer.
  • Asia Pacific is expected to have the fastest growth owing to the rising prevalence of breast cancer.
  • The global players include Ambu, ARGON MEDICAL, Biomedical Srl, BPB Medica, Dragerwerk, Intramedical Imaging, Isoaid, Izi Medical Products & Koninklijke Philips.

Polaris Market Research has segmented the breast lesion localization market report based on type, usage, end user and region:

Breast Lesion Localization, Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Wire Localization
  • Radioisotope Localization
    • Radioguided Occult Lesion Localization (ROLL)
    • Radioactive Seed Localization (RSL)
  • Magnetic Localization
  • Electromagnetic Localization
  • Other Localization Methods

Breast Lesion Localization, Usage Outlook (Revenue - USD Million, 2019 - 2032)

  • Breast Biopsy
  • Breast Conservation (Lumpectomy)

Breast Lesion Localization, End User Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals & Clinics
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
  • Others

Breast Lesion Localization, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Malaysia
  • Latin America
    • Argentina
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa

Breast Lesion Localization Market Report Scope

Report Attributes


Market size value in 2024

USD 351.43 million

Revenue forecast in 2032

USD 546.74 million


5.70% from 2024 – 2032

Base year


Historical data

2019 – 2022

Forecast period

2024 – 2032

Quantitative units

Revenue in USD million and CAGR from 2024 to 2032

Segments covered

By Type, By Usage, By End User, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa


Report customization as per your requirements with respect to countries, region and segmentation.

For Specific Research Requirements

Request for Customized Report